MACRONIX · Intrinsic value
Is Macronix International Co., Ltd. (MACRONIX) overvalued or undervalued?
Macronix International Co., Ltd. (MACRONIX) trades at the delayed market price of NT$123.00 a share. That price already implies revenue growth of more than 25%/yr. TickerWorth's dcf fair value is 18.58 a share (562% above fair value), as of Oct 19, 2026. It is a model estimate, and every input behind it is sourced below.
Model by Miraaj Patel · generated from a hand-researched model · Updated Oct 19, 2026 · How these pages are made
Is MACRONIX overvalued?
- DCF fair value
- 18.58
- Market price
- NT$123.00
- Downside to fair value
- 84.9%
- Verdict
- 562% above fair value
Reverse DCF, on our cash-flow model rather than the fair value above: Today's price implies revenue growth of more than 25%/yr. Above about 25% a year the reverse-DCF stops being informative. It solves for revenue growth alone — holding margins, capital intensity and the forecast horizon fixed — so a price well above our cash-flow model's value has nowhere to go but growth, and the solver returns a rate the model can't reconcile. Read it as "the price implies growth we can't justify", not as a forecast.
Why MACRONIX has no TickerWorth Score
We can't score this company honestly with the data we can see. Rather than publish a number we don't stand behind, we're showing what we do and don't have.
Confidence: Not enough data · Scored
Get the Undervalued Company of the Week.
MACRONIX DCF valuation: what the price assumes
At a recent price of 123.00, Macronix International Co., Ltd. (MACRONIX) trades 562% above TickerWorth's base-case discounted-cash-flow (DCF) fair value of 18.58 per share — meaning the market currently prices MACRONIX overvalued vs our estimate of what the business is intrinsically worth. Our fair value sits below the market, an implied -84.9% move to close the gap if the business performs in line with our assumptions. This is an educational model, not a price target or a recommendation — the value moves with the inputs, which you can test yourself using the WACC slider below.
Read the full reasoning
The valuation discounts Macronix International Co., Ltd.'s projected free cash flows at a weighted-average cost of capital (WACC) of 10.5%, with a long-run terminal growth rate of 2.0%. About 62% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is typical for a stable, cash-generative business and a reminder that small changes in the discount rate or terminal growth assumption swing the intrinsic value meaningfully.
Running the DCF in reverse — solving for the growth the current price already assumes — MACRONIX would need sustained revenue growth of more than 25%/yr to justify today's price, against about 12.0% a year compounded in our base case. We don't quote a precise figure here, because past about 25% a year the reverse-DCF stops being informative: it solves for revenue growth alone, holding margins, capital intensity and the forecast horizon fixed, so a price well above our fair value has nowhere to go but growth. The honest reading is that the price implies growth this model can't reconcile — not that we forecast it.
Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, MACRONIX's modeled DCF value ranges from about 14.04 to 26.81 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.
How to read this page: the DCF fair value is what Macronix International Co., Ltd. would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of MACRONIX's intrinsic value. Figures update as new filings and prices come in.
Every input behind MACRONIX's DCF
| Input | Value |
|---|---|
| Base-year revenueMacronix FY2025; stockanalysis.com (rev + capex cross-checked vs Taipei Times/Digitimes): NOR/NAND/ROM. FY25 was a TROUGH: op LOSS -NT$3.7B (10-quarter loss streak). High D&A (17.5% of rev). Q1'26 swung to profit. | 28,880,000,000 |
| Base EBIT marginMacronix FY2025; stockanalysis.com (rev + capex cross-checked vs Taipei Times/Digitimes): op income -3,698 / revenue 28,880 = -12.8% | -12.8% |
| Forecast revenue growthESTIMATEAssumption — TickerWorth's 5-year explicit forecast | 60% → 5% → -5% → 5% → 5% |
| Risk-free rateTW 10Y govt bond: Taiwan 10Y 1.68% | 1.7% |
| BetaESTIMATEAssumption — normalized estimate: stockanalysis 5yr beta 1.58; used as-is. | 1.58 |
| Terminal growthESTIMATEAssumption — house default: long-run nominal growth in TWD; must be < WACC | 2.0% |
| Diluted sharesshares outstanding / diluted | 1,930M |
| Market priceyfinance live quote: Down 8.4% on 7/17 · as of 2026-07-22T00:15:47+00:00 | 123.00 |
Change MACRONIX's assumptions
The discount-rate dial and the editable model
ProChange growth, margin and WACC yourself — Pro (7-day free trial, card required).
What does Macronix International Co., Ltd. do?
What does it do?
Macronix International Co., Ltd. is a publicly-traded company. A detailed business description isn't available from our free data source.
How does it make money?
How profitable each sales dollar is isn't available from our free data right now — see the multiples lens for the market's read on its earnings power.
Is it financially healthy?
There isn't enough free financial data to judge the balance sheet right now.
MACRONIX insider trading
Insider filings are available for US-listed companies only.
Common questions
What is MACRONIX's intrinsic value?
TickerWorth's base-case DCF fair value for Macronix International Co., Ltd. (MACRONIX) is 18.58 per share, versus a market price of 123.00 (562% above fair value).
Is MACRONIX overvalued or undervalued?
On our DCF model MACRONIX looks overvalued vs fair value at 123.00. This is an educational estimate, not advice.
What discount rate is used for MACRONIX?
A WACC of 10.5% and a terminal growth rate of 2.0%.
Is Macronix International stock undervalued?
TickerWorth's dcf fair value for Macronix International Co., Ltd. (MACRONIX) is 18.58 against a market price of NT$123.00. Our read: 562% above fair value. This is a model estimate, not investment advice.
Macronix International (MACRONIX) DCF valuation and fair value
Our dcf fair value for Macronix International Co., Ltd. (MACRONIX) is 18.58, built on a 10.5% discount rate (WACC) and 2.0% terminal growth. Every assumption is listed on this page with its source.
What growth is priced into Macronix International stock?
Today's price implies revenue growth of more than 25%/yr. Above about 25% a year the reverse-DCF stops being informative. It solves for revenue growth alone — holding margins, capital intensity and the forecast horizon fixed — so a price well above our cash-flow model's value has nowhere to go but growth, and the solver returns a rate the model can't reconcile. Read it as "the price implies growth we can't justify", not as a forecast. This is a reverse DCF: it holds our cash-flow model's other inputs and solves for the revenue growth that makes the model equal today's price of NT$123.00. A model estimate, not investment advice.
Macronix International (MACRONIX) insider trading
We have no recent SEC Form 4 insider filings on file for Macronix International Co., Ltd. (MACRONIX). Form 4 covers US-listed companies only.
How does MACRONIX compare with its peers?
Stocks below our fair value instead
Not investment advice. TickerWorth Score is a model output.
TickerWorth is not a licensed investment adviser, and these figures are estimates from public filings and market data that can be wrong.